India · Delayed Price · Currency is INR Shukra Pharmaceuticals Statistics
Total Valuation
BOM:524632 has a market cap or net worth of INR 11.97 billion. The enterprise value is 11.96 billion.
| Market Cap | 11.97B |
| Enterprise Value | 11.96B |
Important Dates
The last earnings date was Thursday, May 7, 2026.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
BOM:524632 has 439.61 million shares outstanding. The number of shares has increased by 0.75% in one year.
| Current Share Class | 439.61M |
| Shares Outstanding | 439.61M |
| Shares Change (YoY) | +0.75% |
| Shares Change (QoQ) | -0.98% |
| Owned by Insiders (%) | 41.43% |
| Owned by Institutions (%) | n/a |
| Float | 48.48M |
Valuation Ratios
The trailing PE ratio is 54.46.
| PE Ratio | 54.46 |
| Forward PE | n/a |
| PS Ratio | 21.10 |
| PB Ratio | 13.32 |
| P/TBV Ratio | 13.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 304.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.89, with an EV/FCF ratio of -101.37.
| EV / Earnings | 54.22 |
| EV / Sales | 21.09 |
| EV / EBITDA | 35.89 |
| EV / EBIT | 40.03 |
| EV / FCF | -101.37 |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.63 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | -0.43 |
| Interest Coverage | 27.34 |
Financial Efficiency
Return on equity (ROE) is 28.89% and return on invested capital (ROIC) is 31.56%.
| Return on Equity (ROE) | 28.89% |
| Return on Assets (ROA) | 18.29% |
| Return on Invested Capital (ROIC) | 31.56% |
| Return on Capital Employed (ROCE) | 31.67% |
| Weighted Average Cost of Capital (WACC) | 7.31% |
| Revenue Per Employee | 4.93M |
| Profits Per Employee | 1.92M |
| Employee Count | 115 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.33 |
Taxes
In the past 12 months, BOM:524632 has paid 67.28 million in taxes.
| Income Tax | 67.28M |
| Effective Tax Rate | 23.37% |
Stock Price Statistics
The stock price has increased by +105.20% in the last 52 weeks. The beta is 0.55, so BOM:524632's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +105.20% |
| 50-Day Moving Average | 33.12 |
| 200-Day Moving Average | 37.42 |
| Relative Strength Index (RSI) | 38.09 |
| Average Volume (20 Days) | 419,793 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524632 had revenue of INR 567.27 million and earned 220.58 million in profits. Earnings per share was 0.50.
| Revenue | 567.27M |
| Gross Profit | 408.78M |
| Operating Income | 298.80M |
| Pretax Income | 287.87M |
| Net Income | 220.58M |
| EBITDA | 333.23M |
| EBIT | 298.80M |
| Earnings Per Share (EPS) | 0.50 |
Balance Sheet
The company has 59.76 million in cash and 50.20 million in debt, with a net cash position of 9.57 million or 0.02 per share.
| Cash & Cash Equivalents | 59.76M |
| Total Debt | 50.20M |
| Net Cash | 9.57M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 898.49M |
| Book Value Per Share | 2.09 |
| Working Capital | 607.18M |
Cash Flow
In the last 12 months, operating cash flow was 39.31 million and capital expenditures -157.30 million, giving a free cash flow of -117.99 million.
| Operating Cash Flow | 39.31M |
| Capital Expenditures | -157.30M |
| Depreciation & Amortization | 34.43M |
| Net Borrowing | 800,000 |
| Free Cash Flow | -117.99M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 72.06%, with operating and profit margins of 52.67% and 38.88%.
| Gross Margin | 72.06% |
| Operating Margin | 52.67% |
| Pretax Margin | 50.75% |
| Profit Margin | 38.88% |
| EBITDA Margin | 58.74% |
| EBIT Margin | 52.67% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.04%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.04% |
| Dividend Growth (YoY) | -90.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 1.99% |
| Buyback Yield | -0.75% |
| Shareholder Yield | -0.72% |
| Earnings Yield | 1.84% |
| FCF Yield | -0.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 21, 2025. It was a forward split with a ratio of 10.
| Last Split Date | Mar 21, 2025 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |